Evidence map›Paper›PMID 30868769›Full record

ArticleStem cells translational medicine2019

Urea-De-Epithelialized Human Amniotic Membrane for Ocular Surface Reconstruction.

Francisco Bandeira, Gary Hin-Fai Yam, Matthias Fuest, Hon Shing Ong, Yu-Chi Liu, Xin-Yi Seah, Sunny Y Shen, Jodhbir S Mehta

Open access · goldAbstract readCase Reports
In one paragraph

Article in Stem cells translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Francisco BandeiraTissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore.ORCID 0000-0002-7298-4315
Gary Hin-Fai YamTissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore.ORCID 0000-0002-8445-3669
Matthias FuestTissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore.
Hon Shing OngTissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore.
Yu-Chi LiuTissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore.
Xin-Yi SeahTissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore.
Sunny Y ShenSingapore National Eye Centre, Singapore.
Jodhbir S MehtaTissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore.
Singapore Eye Research Institute · SGSingapore National Eye Center · SGNational University of Singapore · SGUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The conjunctiva is a clear tissue covering the white part of the eye and lines the back of the eyelids. Conjunctival diseases, such as symblepharon, cause inflammation, discharges, and photophobia. The treatment often requires excision of large parts of conjunctiva. Tissue engineering of conjunctival cells using human amniotic membrane (HAM) denuded of its epithelium as a basement membrane scaffold has been shown to be effective for covering conjunctival defects. However, most epithelial denudation protocols are time-consuming and expensive or compromise HAM's basement membrane structure and matrix components. We have previously described a method to de-epithelialize HAM using ice-cold urea (uHAM). In this report, we used this method to provide tissue-engineered constructs with cultivated conjunctival epithelial cells on uHAM in two patients, one with a giant conjunctival nevus and the other with a large symblepharon. Autologous conjunctival epithelial cells harvested from incisional biopsies of these two patients were cultured on the uHAM scaffold. The transplantation of tissue-engineered constructs to patients' ocular surface immediately after the removal of lesions showed successful reconstruction of the ocular surface. Postoperatively, there were neither recurrence of lesions nor epithelial defects throughout the follow-up (up to 7 and 19 months, respectively). This report highlights the translational potential of an efficient and inexpensive method to prepare de-epithelialized HAM as a basement membrane scaffold for cell-based tissue-engineered treatments of ocular surface disorders. Stem Cells Translational Medicine 2019;8:620&626.

Indexed as

Re-EpithelializationTissue EngineeringAdolescentAmnionBasement MembraneConjunctivaEpithelial CellsFemaleHumansMaleTransplantation, AutologousUreaUreaCell cultureConjunctivaDe-epithelializationHuman amniotic membraneOcular surface reconstructionTissue engineering

Identifiers

PMID30868769
PMCPMC6591546
OpenAlexW2922319937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.